niacinamide has been researched along with Pancreatic Insufficiency in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the occurrence of malabsorption (MA) in hepatocellular carcinoma (HCC) patients under sorafenib, the potential relationship with pancreatic insufficiency (PI), and the role of pancreatic enzymes supplementation." | 8.02 | Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma. ( Ayuso, C; Belmonte, E; Bruix, J; Darnell, A; Díaz, A; Díaz-González, Á; Feu, F; Forner, A; Gomes da Fonseca, L; Iserte, G; Llarch, N; Reig, M; Rimola, J; Sanduzzi-Zamparelli, M; Sapena, V, 2021) |
| "To describe the occurrence of malabsorption (MA) in hepatocellular carcinoma (HCC) patients under sorafenib, the potential relationship with pancreatic insufficiency (PI), and the role of pancreatic enzymes supplementation." | 4.02 | Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma. ( Ayuso, C; Belmonte, E; Bruix, J; Darnell, A; Díaz, A; Díaz-González, Á; Feu, F; Forner, A; Gomes da Fonseca, L; Iserte, G; Llarch, N; Reig, M; Rimola, J; Sanduzzi-Zamparelli, M; Sapena, V, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-González, Á | 1 |
| Belmonte, E | 1 |
| Sapena, V | 1 |
| Sanduzzi-Zamparelli, M | 1 |
| Darnell, A | 1 |
| Díaz, A | 1 |
| Gomes da Fonseca, L | 1 |
| Llarch, N | 1 |
| Iserte, G | 1 |
| Ayuso, C | 1 |
| Forner, A | 1 |
| Feu, F | 1 |
| Bruix, J | 1 |
| Rimola, J | 1 |
| Reig, M | 1 |
1 other study available for niacinamide and Pancreatic Insufficiency
| Article | Year |
|---|---|
Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Exocrine Pancreatic Insufficiency; Female; Humans; | 2021 |